公司的外文名称缩写 QJBIOCH 公司的法定代表人 朱燕刚 浙江钱江生物化学股份有限公司2025 年半年度报告 二、 联系人和联系方式 董事会秘书 证券事务代表 姓名 陆萍燕 蒋振伟 联系地址 浙江省海宁市海洲街道钱江西路178号钱 浙江省海宁市海洲街道钱江西路178号钱 江大厦 江大厦 电话 0573-87088718 0573-87038237 传真 0573-87035640 0573-87035640 电子信箱 qjbioch@600796.com qjbioch@600796.com 三、 基本情况变更简介 公司注册地址 浙江省海宁市海洲街道钱江西路178号钱江大厦19-21层 公司注册地址的历史变更情况 1999年12月21日，公司注册地址由"浙江省海宁市硖石镇南"变更 为"浙江省海宁市硖石镇西山路598号"；2006年8月8日，公司注 册地址由"浙江省海宁市硖石镇西山路598号"变更为"浙江省海 宁市西山路598号"；2010年7月14日，公司注册地址由"浙江省海 宁市西山路598号"变更为"浙江省海宁市西山路598号7楼"；2016 年9月9日，公司注册地址由"浙江省海宁市西山路598号7楼 ...

主要产品 2025 年 1-6 月产量 （吨） 2025 年 1-6 月销量 （吨） 2025 年 1-6 月销售 金额（万元） 杀菌剂 3,033.70 3,188.00 25,260.21 杀虫剂 1,677.17 2,029.64 16,126.67 其它 1,282.02 1,214.48 6,880.43 一、主要产品的产量、销量及收入实现情况（不含税） 三、主要原材料的价格变动情况（不含税） | 主要原材料 | 2025 年 1-6 月平均 进价（万元/吨） | 2024 年 1-6 月平均 进价（万元/吨） | 变动比率（%） | | --- | --- | --- | --- | | 苯醚甲环唑 | 8.47 | 8.91 | -4.98 | | 吡唑醚菌酯 | 14.22 | 15.19 | -6.36 | | 氟啶虫酰胺 | 24.65 | 30.02 | -17.89 | | 甲维盐 | 62.47 | 46.33 | 34.84 | | 甲基硫菌灵 | 2.98 | 3.39 | -12.16 | 证券代码：605033 证券简称：美邦股份 公告编号：2025-042 陕西美邦药业集团 ...

| 市场数据：2025 年 8 月 | 25 日 | | | --- | --- | --- | | 收盘价（元）： | | 71.25 | | 年内最高/最低（元）： | | 71.77/46.12 | | 流通A股/总股本（亿）： | | 4.04/4.05 | | 流通 A 股市值（亿）： | | 287.84 | | 总市值（亿）： | | 288.85 | | 年 基础数据：2025 | 月 6 | 日 30 | | | --- | --- | --- | --- | | 基本每股收益(元)： | | | 2.00 | | 摊薄每股收益(元)： | | | 2.00 | | 每股净资产(元)： | | | 27.45 | | 净资产收益率(%)： | | | 7.24 | 公司近一年市场表现 分析师： 李旋坤 执业登记编码：S0760523110004 邮箱：lixuankun@sxzq.com 王金源 执业登记编码：S0760525080001 邮箱：wangjinyuan@sxzq.com 农药 扬农化工（600486.SH） 买入-B(维持) 投资建议 预计公司 2025-2027 年归母净利 ...

上 市 公 司 基础化工 2025 年 08 月 25 日 润丰股份 (301035) —— 运营质量持续改善，Model C 业务渐入佳境 报告原因：有业绩公布需要点评 买入（维持） | 市场数据： | 2025 年 08 月 22 日 | | --- | --- | | 收盘价（元） | 72.41 | | 一年内最高/最低（元） | 78.47/35.70 | | 市净率 | 2.9 | | 股息率%（分红/股价） | 0.81 | | 流通 A 股市值（百万元） | 20,300 | | 上证指数/深证成指 | 3,825.76/12,166.06 | | 注："股息率"以最近一年已公布分红计算 | | | 基础数据: | 2025 年 06 月 30 日 | | --- | --- | | 每股净资产（元） | 25.22 | | 资产负债率% | 54.30 | | 总股本/流通 A 股（百万） | 281/280 | | 流通 B 股/H 股（百万） | -/- | 一年内股价与大盘对比走势： 08-22 09-22 10-22 11-22 12-22 01-22 02-22 03-22 04- ...

事件： 公司发布 2025 年中报，实现营收62.3 亿元，同比增9.4%，实现归母净利润8.1 亿元，同比增5.6%。其 中25Q2 单季度营收29.9 亿元 ，同比增18.6%，归母净利润3.7 亿元，同比增11.1%。 点评： 主要产品销量增加，公司业绩同比增长 25H1 公司原药和制剂收入分别为36.6 亿元、11.7 亿元，同比分别增10.0%、降2.8%，其中原药销量5.67 万吨同比增13.4%，均价6.45 万元/吨同比降3.0%；制剂销量2.81 万吨同比增0.1%，均价4.16 万元/吨同 比降2.9%。得益于新产能释放，公司上半年销量同比增长，但产品价格仍有所承压。25H1 公司毛利率 23.6%，同比降0.6pct，净利率12.9%，同比降0.5pct。25H1 公司经营性现金流净额17.3 亿元，同比降 34.3%，主要系公司购买原料、商品支付的现金同比增加。 海外库存去化，农药景气有望回升 前期受行业新增产能冲击以及海外农化巨头去库影响，多数农药产品价格持续下跌。当前全球农药分销 渠道库存经过持续消化已降至相对合理水平，叠加农药协会开展"正风治卷"行动，看好后续农药行业景 气修复。 ...

风险提示：股市有风险，投资需谨慎。 农心科技主营业务为农药制剂产品的研发、生产和销售。公司产品涵盖杀虫剂、杀菌剂、除草剂等系列 产品，广泛应用于农业生产领域。公司注册地位于陕西省，属于农药兽药行业。 公司在互动平台披露，截至2025年8月20日，公司股东人数为9701户。这一数据较此前披露的股东人数 有所变化。 农心科技股价报21.41元，较前一交易日下跌0.59元，跌幅2.68%。当日开盘价为22.00元，最高触及 22.00元，最低下探至21.19元，成交量为18093手，成交金额达0.39亿元。 ...

Summary of Key Points Core Viewpoint - Jiangsu Fengshan Group Co., Ltd. held a half-year performance briefing on August 19, 2025, to discuss its financial results and future strategies, highlighting significant revenue growth and ongoing projects in the agricultural chemicals and new energy sectors [1][2]. Group 1: Financial Performance - For the first half of 2025, the company achieved a revenue of 619 million yuan, representing an increase of 18.74% year-on-year [4]. - The net profit attributable to shareholders was 30 million yuan, showing a substantial rise of 235.40% compared to the previous year, driven by a recovery in the pesticide industry and successful market expansion efforts [4]. Group 2: Product and Market Development - The company reported that its pesticide categories (insecticides, herbicides, and fungicides) have been performing well, with specific revenue contributions detailed in prior disclosures [3]. - The company is actively pursuing a "second growth curve" by exploring projects in new energy electrolyte and fine chemical new materials, alongside its established pesticide business [5][6]. Group 3: Project Updates - The Hubei project commenced trial production on January 8, 2025, with products already being sold in batches, indicating progress in operational plans [5]. - The Hubei project is expected to produce various chemical products, including ortho-chlorotoluene and its derivatives, which are essential for pharmaceuticals and agricultural chemicals [9][10]. Group 4: Strategic Direction - The company aims to enhance its pesticide, new energy electronic chemicals, and fine chemical new materials sectors, focusing on quality improvement, market demand alignment, and safety management [6]. - The company anticipates that the pesticide industry will continue to grow due to increasing global food demand, emphasizing the importance of innovation and international market expansion [7]. Group 5: Research and Development - Research and development investments are focused on innovations in pesticide production processes, new product formulations, and the development of new electrolyte products for sodium-ion and lithium-ion batteries [11].

Core Viewpoint - Shenzhen Noposion Agrochemical Co., Ltd. reported a revenue increase of 8.20% year-on-year for the first half of 2025, driven by growth in its specialty fresh consumption and pesticide formulation businesses [1][2]. Company Overview and Key Financial Indicators - The company did not distribute cash dividends or issue bonus shares for the reporting period [1]. - Total revenue for the first half of 2025 was approximately CNY 3.68 billion, compared to CNY 3.40 billion in the same period last year [2]. - Net profit attributable to shareholders increased by 17.35% to approximately CNY 648 million [2]. - The company’s total assets grew by 9.33% to approximately CNY 12.28 billion [2]. Business Operations - The company focuses on the specialty fresh consumption sector, particularly blueberries, and aims to establish a comprehensive supply chain for this product [3][4]. - Noposion has been enhancing its agricultural technology services and distribution channels, particularly in the pesticide formulation sector, to strengthen its market position [5][6]. Financial Performance Analysis - Revenue from the pesticide formulation business was approximately CNY 1.49 billion, representing a growth of 8.94% [8]. - The specialty fresh consumption business generated approximately CNY 1.82 billion, with an increase of 18.62% year-on-year [8]. - The company’s operating costs rose by 6.29% to approximately CNY 2.29 billion, reflecting the increase in revenue [8]. Competitive Advantages - The company has established a strong distribution network and technical service team, enhancing its ability to serve large agricultural producers [5]. - Noposion's focus on a single crop strategy allows for a more integrated approach to product and service offerings, which has been well-received by farmers [4][5]. - The company has invested in modern agricultural practices, including automated and technology-driven farming methods, which create high barriers to entry in the industry [4]. Cash Flow and Investment Activities - The net cash flow from operating activities was approximately CNY 254 million, a decrease of 20.19% compared to the previous year [8]. - The net cash flow from investment activities improved significantly, with a reduction in outflows by 65.03% [8]. - The net cash flow from financing activities decreased by 83.38%, indicating reduced borrowing [8].

Core Viewpoint - The company reported a significant improvement in its financial performance for the first half of 2025, driven by a recovery in the pesticide industry and effective cost management [4][5]. Financial Performance - In the first half of 2025, the company achieved operating revenue of 2.083 billion yuan, a year-on-year increase of 7.3% [4]. - The net profit attributable to shareholders reached 42 million yuan, marking a substantial year-on-year increase of 117.8% [4]. - For the second quarter of 2025, the company reported operating revenue of 1.163 billion yuan, up 7.5% year-on-year and 26.4% quarter-on-quarter [4]. - The net profit attributable to shareholders for Q2 2025 was 26 million yuan, reflecting a year-on-year increase of 122.3% and a quarter-on-quarter increase of 53.3% [4]. Market Demand and Product Performance - The pesticide market demand has rebounded, with the company’s herbicides, insecticides, fungicides, and regulators generating revenues of 1.06 billion, 790 million, 170 million, and 80 million yuan respectively, with year-on-year changes of +14.8%, +0.5%, -3.3%, and +40.1% [5]. - The gross profit margins for these products were 11.1%, 15.7%, 13.9%, and 26.9%, with year-on-year changes of -4.1, +8.6, -0.1, and +17.3 percentage points respectively [5]. - The company’s export sales reached 1.087 billion yuan, a year-on-year increase of 19.61%, supported by international market demand recovery and proactive customer engagement [5]. Production Capacity and Market Coverage - As of the end of 2024, the company had a raw material production capacity of 43,910 tons per year and a formulation capacity of 20,000 tons per year, with an additional 5,500 tons per year of raw material capacity under trial or construction [6]. - The company has established a comprehensive sales network across over 30 provinces in China and holds registrations for over 40 types of raw materials and 150 types of formulations, ensuring adaptability to various agricultural needs [6]. - The company has self-operated import and export rights and has formed stable partnerships with several multinational companies, enhancing its competitive edge in international markets [6].

Investment Rating - The report maintains an "Accumulate" rating for the company [6]. Core Views - The pesticide industry is experiencing a recovery in market demand, leading to a significant improvement in the company's net profit attributable to shareholders in the first half of 2025 [1][2]. - The company achieved a revenue of 2.083 billion yuan in 25H1, a year-on-year increase of 7.3%, and a net profit of 42 million yuan, up 117.8% year-on-year [1]. - The company is focusing on optimizing its product structure and accelerating overseas market registration to capture orders, resulting in export sales of 1.087 billion yuan, a year-on-year increase of 19.61% [2]. Summary by Sections Financial Performance - In 25H1, the company reported revenues from herbicides, insecticides, fungicides, and regulators of 1.06 billion, 790 million, 170 million, and 80 million yuan respectively, with year-on-year changes of +14.8%, +0.5%, -3.3%, and +40.1% [2]. - The gross margins for these products were 11.1%, 15.7%, 13.9%, and 26.9%, with year-on-year changes of -4.1, +8.6, -0.1, and +17.3 percentage points [2]. Capacity and Production - As of the end of 2024, the company has a raw material production capacity of 43,910 tons per year and a formulation capacity of 20,000 tons per year, with an additional 5,500 tons per year of raw material capacity under trial operation or construction [3]. - The company is advancing its production debugging and safety production for the relocation project along the Yangtze River, which is expected to support its performance in 2025 [2]. Profit Forecast and Valuation - The report adjusts the profit forecast for 2025-2026 downwards, with the expected net profits for 2025, 2026, and 2027 being 74 million, 128 million, and 181 million yuan respectively [4]. - The company is expected to benefit from the release of its construction capacity, which will support sustainable and healthy development [4].